Company intelligence / Profile preview

Neckermann Industria Farmaceutica

São Paulo, São Paulo, Brazilgrupocimed.com.br ↗

Ownership: Private
Development stage: Other

Overview

Neckerman Indústria Farmacêutica (now operating as Onefarma or 1Farma) is a Brazilian pharmaceutical company that operates as a subsidiary of Grupo Cimed. The company specializes in the commercialization and distribution of generic and similar (branded generic) medicines in Brazil. Its product portfolio includes a wide range of small molecule therapeutics covering therapeutic areas such as cardiovascular health, infectious diseases, endocrinology, and pain management. All of its products are manufactured at Grupo Cimed's state-of-the-art manufacturing facility in Pouso Alegre, Minas Gerais, and registered under ANVISA regulations.

Therapeutic areas: ImmunologyNeurologyInfectious DiseasesCardiovascularEndocrinology
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Neckermann Industria Farmaceutica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neckermann Industria Farmaceutica.